RGCC Cancer screening

Cancer is a disease that fills patients with fear and uncertainty, regardless of the cancer type and the stage of the disease. The diagnosis can profoundly change the lives of both patients and their families. In the midst of these emotional challenges, however, a cancer blood test offers hope: The vast range of RGCC tests has the potential to improve the early detection of cancer and thus increases the chances of successful treatment.

Through tailored tests, RGCC aims to empower people facing cancer with tailored insights that can change the course of their journey. The aim of the cancer blood tests is to detect, analyze and examine cancer cells early at every stage of the disease. The minimally invasive liquid biopsy test offer promising opportunities for early cancer detection and treatment. In this process, the focus is always on providing patients with a clinical basis on which they can make a well-founded and personalized decision for individual cancer treatment. 

Liquid Biopsy

The liquid biopsies represent a transformative approach to cancer testing and research, offering distinct advantages over traditional tissue biopsies. Minimally invasive and more convenient, liquid biopsies involve a simple blood draw, making them patient-friendly. Moreover, they are cost-effective, enhancing accessibility for patients and healthcare practitioners alike.

Additionally, unlike traditional biopsies that offer insights from one specific location in the body, liquid biopsies capture information from distant (metastatic) sites as well. This means that liquid biopsies paint a complete picture of cancer throughout the patient's body, offering a comprehensive perspective that can be invaluable for precise diagnosis and treatment planning.

Onco-D-Clare

Onco-D-Clare is a cancer screening test designed to identify cancer even before the symptom's onset. With the ease of a simple blood draw, you can now detect cancer long before any symptoms emerge. Onco-D-clare opens an early door to personalized health insights. 

How dose Onco-D-Clare work? 

  • Onco-D-clare is based on the synergy of molecular biology with machine learning algorithms. Peripheral blood mononuclear cells are isolated from blood samples, and gene expression analysis is performed on more than 90 genes. The expression profile is then used to classify the sample as healthy or indicating a positive immune response to cancer cells

How does Onco-D-Clare help? 

  • The Onco-D-clare test goes beyond traditional screening, aiming to detect cancer at it's earliest stages. It is designed as an early screening tool for individuals who do not have a cancer diagnosis but may want to stay informed about their risk. This is especially useful for those who have a family history of cancer or other risk factors. 

Onconomics Plus

Onconomics Plus offers a comprehensive solution for selecting personalized treatment plans. This test evaluates the chemosensitivity of both conventional drugs and natural substances, determining the effectiveness of various chemotherapeutic agents. Additionally, it assesses tumor cell sensitivity to natural extracts, identifying which supplements are beneficial. The test also provides insights into the effectiveness of hyperthermia and radiation treatments on cancer, integrating this information with genetic data for a holistic approach to therapy selection

How does Onconomics Plus work?

  • Onconomics Plus enables the individualized treatment of patient's cancers using both conventional chemotherapies, as well as natural therapies
  • This test assists practitioners in determining the best possible treatment approach for each individual situation. 
  • The results categorize the effectiveness of a chemotherapy agent as follows: below 30%, 31-80%, and above 80% effectiveness against cancer 

How does Onconomics Plus help? 

  • Onconomics plus compiles extensive data on the effectiveness of conventional treatments, distinguishing between effective and ineffective options. It can also provide insights into natural compounds that can effectively combat cancer. 
  • The artful selection of conventional and natural agents, when combined, creates a comprehensive treatment plan addressing the cancer, targeting cancer stem cells, and mitigating the spread of the disease.Â